SCHEMBL14613755

SCHEMBL14613755

C[C@H](NC(=O)c1ccc(C(O)CCc2cccc(O)c2)cc1Cl)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ITGAL P20701 1/20 0.45
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ ITGB1 P05556 1/20 0.41
▸ ITGA4 P13612 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ S1PR1 P21453 3/20 0.40
▸ DRD3 P35462 2/20 0.39
▸ HTR2B P41595 2/20 0.39
▸ SLC6A3 Q01959 2/20 0.39
▸ S1PR4 O95977 1/20 0.39
▸ TSPO P30536 1/20 0.39
▸ MRGPRX4 Q96LA9 1/20 0.39
▸ PYGL P06737 1/20 0.39
▸ CYP2D6 P10635 2/20 0.38
▸ ADRB2 P07550 2/20 0.38
▸ ADRB1 P08588 2/20 0.38
▸ ADRA2A P08913 2/20 0.38
▸ ADRA1D P25100 2/20 0.38
▸ ADRA1A P35348 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13668215 0.92 ITGAL (0.51) ITGALMEN1KMT2AITGB1ITGA4
SCHEMBL3875155 0.84 ADRB1 (0.47) ITGALDRD3HTR2BSLC6A3CYP2D6
SCHEMBL13923450 0.82 EGFR (0.44) ITGALPOLBDRD3HTR2BSLC6A3
SCHEMBL13666886 0.81 ITGAL (0.65) ITGALITGB1ITGA4S1PR1DRD3
SCHEMBL7231159 0.81 ITGAL (0.38) ITGALMEN1KMT2AITGB1ITGA4
SCHEMBL14614027 0.80 S1PR1 (0.43) MEN1KMT2AITGB1ITGA4POLB
SCHEMBL18867719 0.80 ITGAL (0.59) ITGALITGB1ITGA4S1PR1DRD3
SCHEMBL3868781 0.80 ITGAL (0.49) ITGALMEN1KMT2AITGB1ITGA4
SCHEMBL13666039 0.79 ITGAL (0.47) ITGALMEN1KMT2AITGB1ITGA4
SCHEMBL3868772 0.79 ITGAL (0.76) ITGALITGB1ITGA4HPGDOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1754705-A2 Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders Genentech, Inc. (US) 2007-02-21 — — EP disclosed
EP-1063982-B1 ANTAGONISTS FOR TREATMENT OF CD11/CD18 ADHESION RECEPTOR MEDIATED DISORDERS GENENTECH INC (US) 2007-02-14 — — EP disclosed
Send feedback